The BioCity UK Life Sciences Start-up report now has the benefit of 12 years of data on the creation and funding of life science companies. The document below highlights key findings from the report and demonstrates the impact the life sciences industry has in Scotland. To download the report findings, click here. To access the full report, click here.
Scotland’s wealth of experience, knowledge and capabilities in life and chemical sciences is now at your fingertips with the Life & Chemical Sciences company directory. This new interactive visual interface offers a gateway to over 1000 companies and organisations (academic organisations, research centres and trade associations) across the breadth of the life and chemical sciences sector in Scotland. This searchable user friendly tool allows visitors to...
Concept Life Sciences’ recent acquisition of Aquila BioMedical has quickly produced a return—an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs. Aquila will run a few in vitro, in vivo and ex vivo analyses to help Macrophage decide on the best candidate to enter the clinic. U.K.-based Macrophage targets cancer with its proprietary Esterase Sensitive Motif (ESM) technology, which delivers small-molecule drugs...
Life sciences incubation business, BioCity, are set to further expand in Aberdeen’s world-class life sciences cluster following success at the headquarters in Nottingham. Delivered by BioCity Group in partnership with private sector economic development body Opportunity North East (ONE), the ONE Life Sciences Accelerator Programme will launch with a boot camp in early December, followed by a 12-week DEVELOP programme starting in January 2018. Toby...
We are delighted to open the call for nominations for this year’s Life Sciences Awards. There are seven awards this year including three new categories designed to shine a light on the sector’s global successes and rising stars: Business Leadership Award (2017) Rising Stars: Extraordinary Talent (2017) Rising Stars: High-Growth Company (2017) Innovation Award Innovative Collaboration Award Global Impact Award Investment of the Year Award...
Capsugel announced that they have expanded clinical trial capabilities as well as increased development and manufacturing capabilities for specialised drug products using liquid-filled hard capsule (LFHC) technology. The expansion at Capsugel’s Edinburgh facility will also include a new isolators for high containment pre-dispensing and compounding, high- and low-shear compounding and holding tanks, an additional high-speed encapsulation machine, a capsule banding unit, and added high-containment capabilities for...